Integer Holdings Co. (NYSE:ITGR) Given Consensus Recommendation of “Moderate Buy” by Brokerages

Integer Holdings Co. (NYSE:ITGR) has been assigned an average rating of “Moderate Buy” from the eight analysts that are presently covering the stock, Marketbeat.com reports. Two research analysts have rated the stock with a hold recommendation and six have assigned a buy recommendation to the company. The average 12 month target price among brokers that have issued a report on the stock in the last year is $149.00.

Several brokerages recently commented on ITGR. Benchmark lifted their price target on shares of Integer from $140.00 to $150.00 and gave the stock a “buy” rating in a research note on Friday, February 21st. Wells Fargo & Company reiterated an “overweight” rating and set a $160.00 price target on shares of Integer in a research note on Tuesday, December 3rd. Citigroup lifted their price target on shares of Integer from $130.00 to $145.00 and gave the stock a “neutral” rating in a research note on Wednesday, December 11th. Truist Financial lifted their price target on shares of Integer from $147.00 to $163.00 and gave the stock a “buy” rating in a research note on Wednesday, December 11th. Finally, Oppenheimer downgraded shares of Integer from an “outperform” rating to a “market perform” rating in a research report on Friday, February 21st.

Integer Price Performance

Shares of ITGR opened at $117.76 on Wednesday. Integer has a twelve month low of $107.11 and a twelve month high of $146.36. The firm’s fifty day simple moving average is $134.11 and its 200-day simple moving average is $132.76. The firm has a market capitalization of $3.96 billion, a price-to-earnings ratio of 35.05, a PEG ratio of 1.72 and a beta of 1.24. The company has a current ratio of 2.95, a quick ratio of 2.09 and a debt-to-equity ratio of 0.62.

Integer (NYSE:ITGR) last announced its quarterly earnings results on Thursday, February 20th. The medical equipment provider reported $1.43 EPS for the quarter, missing the consensus estimate of $1.46 by ($0.03). Integer had a return on equity of 11.65% and a net margin of 6.92%. The company had revenue of $449.50 million for the quarter, compared to analyst estimates of $446.28 million. Equities analysts forecast that Integer will post 6.01 EPS for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the business. Mather Group LLC. boosted its holdings in shares of Integer by 304.3% in the fourth quarter. Mather Group LLC. now owns 190 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 143 shares in the last quarter. Lee Danner & Bass Inc. purchased a new stake in shares of Integer in the fourth quarter valued at about $27,000. Huntington National Bank boosted its holdings in shares of Integer by 8,933.3% in the third quarter. Huntington National Bank now owns 271 shares of the medical equipment provider’s stock valued at $35,000 after acquiring an additional 268 shares in the last quarter. R Squared Ltd purchased a new stake in shares of Integer in the fourth quarter valued at about $44,000. Finally, Sterling Capital Management LLC boosted its holdings in shares of Integer by 472.9% in the fourth quarter. Sterling Capital Management LLC now owns 338 shares of the medical equipment provider’s stock valued at $45,000 after acquiring an additional 279 shares in the last quarter. 99.29% of the stock is owned by hedge funds and other institutional investors.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.